CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$192M
1-Year Return
17.05%
This Quarter Return
-2.78%
1 Year Return
+17.05%
3 Year Return
+45.89%
5 Year Return
+105.96%
10 Year Return
+138.93%
AUM
$550M
AUM Growth
-$25.8M
(-4.5%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
8.93%
Holding
683
New
116
Increased
168
Reduced
251
Closed
120
Top Buys
| 1 |
Intel
INTC
|
$2.17M |
| 2 |
AT&T
T
|
$2.1M |
| 3 |
Chubb
CB
|
$1.93M |
| 4 |
Clorox
CLX
|
$1.89M |
| 5 |
HCA Healthcare
HCA
|
$1.88M |
Top Sells
| 1 |
Wabtec
WAB
|
$2.95M |
| 2 |
Marathon Petroleum
MPC
|
$2.83M |
| 3 |
Occidental Petroleum
OXY
|
$2.71M |
| 4 |
Dow Inc
DOW
|
$2.68M |
| 5 |
Citizens Financial Group
CFG
|
$2.32M |
Sector Composition
| 1 | Technology | 17.49% |
| 2 | Financials | 16.43% |
| 3 | Healthcare | 14.65% |
| 4 | Industrials | 13.25% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
ALX Oncology
ALXO
$62.7M
| $168K | 0.03% |
35,071
+2,288
| +7% | +$11K |
|
502
Cullinan Oncology
CGEM
$411M
| $168K | 0.03% |
18,591
-204
| -1% | -$1.85K |
|
503
MacroGenics
MGNX
$118M
| $165K | 0.03% |
35,343
-390
| -1% | -$1.82K |
|
504
Zymeworks
ZYME
$1.13B
| $163K | 0.03% |
+25,755
| New | +$163K |
|
|
LENZ
505
LENZ Therapeutics
LENZ
$1.18B
| $163K | 0.03% |
9,362
-128
| -1% | -$2.22K |
|
|
IMA
506
ImageneBio, Inc. Common Stock
IMA
$94.5M
| $161K | 0.03% |
3,104
-92
| -3% | -$4.78K |
|
507
Alector
ALEC
$280M
| $159K | 0.03% |
24,532
+322
| +1% | +$2.09K |
|
508
Nuvation Bio
NUVB
$1.21B
| $158K | 0.03% |
118,057
-1,228
| -1% | -$1.65K |
|
509
Enanta Pharmaceuticals
ENTA
$185M
| $157K | 0.03% |
+14,015
| New | +$157K |
|
510
MeiraGTx Holdings
MGTX
$609M
| $156K | 0.03% |
31,866
-337
| -1% | -$1.66K |
|
511
Athira Pharma
ATHA
$15.6M
| $152K | 0.03% |
75,389
+136
| +0.2% | +$275 |
|
|
LIAN
512
DELISTED
LianBio American Depositary Shares
LIAN
| $151K | 0.03% |
101,039
-1,198
| -1% | -$1.79K |
|
513
Kymera Therapeutics
KYMR
$3.07B
| $149K | 0.03% |
+10,753
| New | +$149K |
|
514
Edgewise Therapeutics
EWTX
$1.59B
| $149K | 0.03% |
26,023
+916
| +4% | +$5.25K |
|
515
Pyxis Oncology
PYXS
$122M
| $149K | 0.03% |
74,903
-1,002
| -1% | -$1.99K |
|
516
Nurix Therapeutics
NRIX
$755M
| $145K | 0.03% |
18,511
-245
| -1% | -$1.93K |
|
|
ITOS
517
DELISTED
iTeos Therapeutics
ITOS
| $144K | 0.03% |
13,188
+631
| +5% | +$6.91K |
|
518
Iovance Biotherapeutics
IOVA
$850M
| $144K | 0.03% |
31,714
-450
| -1% | -$2.05K |
|
519
Generation Bio
GBIO
$40M
| $143K | 0.03% |
3,768
-38
| -1% | -$1.44K |
|
520
Lyell Immunopharma
LYEL
$241M
| $143K | 0.03% |
+4,856
| New | +$143K |
|
521
Vanda Pharmaceuticals
VNDA
$267M
| $142K | 0.03% |
32,895
-108
| -0.3% | -$467 |
|
|
KLRS
522
Kalaris Therapeutics, Inc. Common Stock
KLRS
$89M
| $141K | 0.03% |
2,846
-37
| -1% | -$1.83K |
|
523
Monte Rosa Therapeutics
GLUE
$300M
| $133K | 0.02% |
27,844
-348
| -1% | -$1.67K |
|
524
Cue Biopharma
CUE
$59.6M
| $133K | 0.02% |
57,888
-775
| -1% | -$1.78K |
|
|
GRTS
525
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $132K | 0.02% |
76,811
-1,037
| -1% | -$1.78K |
|